Literature DB >> 25910316

Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy.

Ahmet Emre Eskazan1, İbrahim Hatemi, Seniz Öngören Aydın, Muhlis Cem Ar, Teoman Soysal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25910316     DOI： 10.5152/tjg.2014.5281

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN： 1300-4948            Impact factor:   1.852


× No keyword cloud information.
  3 in total

Review 1.  Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.

Authors:  Dilek Keskin; Sevil Sadri; Ahmet Emre Eskazan
Journal:  Drug Des Devel Ther       Date:  2016-10-13       Impact factor: 4.162

Review 2.  Tyrosine Kinase Inhibitor-Associated Platelet Dysfunction: Does This Need to Have a Significant Clinical Impact?

Authors:  Nurgul Ozgur Yurttas; Ahmet Emre Eskazan
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

3.  Recurrent Gastrointestinal Hemorrhage in Children with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with Dasatinib: Case Reports.

Authors:  Xin Liao; Yuxia Guo; Yali Shen; Jianwen Xiao
Journal:  Case Rep Hematol       Date:  2020-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.